QualityStocksNewsBreaks Archives - Page 208 of 1508

WednesdayAug 14, 2024 11:01 am

QualityStocksNewsBreaks – Torr Metals Inc. (TSXV: TMET) Appoints Global Mining Sector Veteran to the Board of Directors

Torr Metals (TSX.V: TMET), a Vancouver-based mineral exploration company, today announced the appointment of Mr. Gordon Maxwell, P.Geo, as a new member of its Board of Directors. Gordon is a highly distinguished B.Sc. Hon. Geologist from the University of Manitoba with nearly four decades of experience across the global mining sector, holding significant leadership roles at Noranda Exploration, Xstrata, and Glencore. In addition, his contributions to the Canadian mining industry have earned him prestigious industry accolades. “We are thrilled to welcome Gordon to Torr Metals. With his wealth of knowledge in the regions and mineralizing systems central to our project,…

TuesdayAug 13, 2024 10:13 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Signs Definitive Loan Restructuring Agreement with EIB Converting Debt into Equity

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the signing of a definitive Loan Restructuring Agreement with the European Investment Bank (“EIB”), its lender. The agreement also included an amendment and restatement to the Finance Contract between the parties. According to the announcement, an amount equal to approximately €26.6 million (approximately $29 million), including interest accrued to date, owned by Scinai to EIB under the finance contract, will be converted into 1,000 preferred shares, no par value per share, of…

TuesdayAug 13, 2024 9:32 am

QualityStocksNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Releases Q2 2024 Quarterly Update

SOBRsafe (NASDAQ: SOBR), a provider of next-generation, transdermal alcohol-detection solutions, is reporting on its NASDAQ listing, financial positioning and sales progress, noting that the NASDAQ Hearings Panel granted the company an exception period continuing the listing of its common stock on the NASDAQ exchange; the company has until Oct. 23, 2024, to regain compliance with the market’s $1 minimum bid price per share requirement and to demonstrate long-term compliance with the required minimum of $2.5 million in stockholders' equity. The report also noted that the company continues to strengthen its financial position and restructure the composition of its equity. In…

MondayAug 12, 2024 11:15 am

ECGI Holdings Inc. (ECGI) Makes Good Use of Luxury Equestrian Market to Additionally Grow Its Expanding Customer Base

ECGI Holdings is targeting a share of the growing luxury goods market by designing, manufacturing, and selling luxury equestrian apparel and equipment through its subsidiary Pacific Saddlery The company sees the utilization of smaller focused markets as a proven entrance pathway to much larger general luxury markets Bain & Company valued the global luxury goods market at €362 billion ($395.4 billion) in 2023 and expects this market to grow to between €540 billion ($589.8 billion) and €580 billion ($633.5 billion) by 2030 ECGI Holdings and Pacific Saddlery are using celebrated brands like Hermès, Gucci, and Ralph Lauren as a template…

MondayAug 12, 2024 10:57 am

QualityStocksNewsBreaks – HealthLynked Corp. (HLYK) Partners with RxSpark to Provide Integrated Solution for Medication Management

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced a strategic partnership with RxSpark, a platform dedicated to providing affordable prescription medications and healthcare services. According to the announcement, this partnership will enhance the patient’s experience by integrating HealthLynked’s advanced healthcare network with RxSpark’s pharmacy discounts and prescription price comparison tool. Through this exciting integration, HealthLynked members can find savings of up to 90% off their medications, easily manage their prescriptions, and ensure timely access to necessary medications. Key benefits include enhanced prescription management, improved access to affordable medications, streamlined healthcare experience, and cost savings for patients. “At HealthLynked,…

MondayAug 12, 2024 10:43 am

QualityStocksNewsBreaks – Upstream Lists Advantages of Trading Powered by Blockchain Tech

Upstream, a MERJ Exchange stock market and global trading app, is powered by blockchain technology, which is self-sufficient and operates continuously. That model means that stock markets could operate 24/7 with instantaneous settlement, which changes the landscape, particularly during market sell-offs. The advantages of that were discussed in a recent Upstream article. The article noted that “this past Monday morning, the Dow Jones Industrial Average fell more than 1,000 points. The Nikkei 225, an index of leading stocks in Tokyo, closed down 5.8% Friday, and then 12.4% on Monday.” The article observed that because of traditional stock-trading hours, an entire…

MondayAug 12, 2024 10:30 am

Clene Inc.’s (NASDAQ: CLNN) Makes Significant Strides in Developing its Lead Agent, CNM-Au8(R), to Address Neurodegenerative Conditions

Clene has conducted five Phase 2 clinical trials, three with long-term extensions, and three expanded access programs (with additional studies ongoing) to evaluate the safety and efficacy of CNM-Au8 The global ALS treatment market is poised for growth, driven by an aging population and limited current treatment options CNM-Au8 works by improving cellular energy production and utilization, which is crucial for maintaining neuronal health, and is at a deficit in neurodegenerative diseases Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative…

MondayAug 12, 2024 9:12 am

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Shareholders Approve Plans for Share Consolidation, Name Change

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is planning to consolidate its issued and outstanding class A multiple voting shares and class B subordinate voting shares. The company also has announced a planned name change to Quantum BioPharma Ltd, with a new trading symbol of QNTM. The consolidation, which is part of the company’s efforts to regain compliance with NASDAQ’s minimum bid price, and name change are subject to approval by the NASDAQ exchange; if approved, the changes will be effective Aug. 15, 2024. These…

FridayAug 09, 2024 2:07 pm

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports on Status of New Product, Investment in Celly Nutrition Corp.

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is providing a status report on its investment in Celly Nutrition Corp. A privately held Canadian company, Celly Nu is launching an innovative beverage product designed to assist in expediting alcohol metabolism and faster recovery from alcohol consumption. According to the update, Celly Nu has announced the imminent launch of its revolutionary, great-tasting, scientifically backed product, unbuzzd(TM). The product will be available in 3-pack or 18-pack options, and the compact packages can easily be carried in a pocket…

FridayAug 09, 2024 1:56 pm

QualityStocksNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) Faces Antitrust Scrutiny Amid Market Dominance

Alphabet (NASDAQ: GOOGL, GOOG), the parent company of Google, is currently facing a challenging period, with antitrust scrutiny at the forefront of its concerns. Despite the complexities surrounding the antitrust ruling, experts from Barron’s suggest that Google’s market dominance is unlikely to be significantly impacted by the label of being a monopolist. However, it’s important to note that other risks loom large, potentially threatening the tech giant’s position. The recent performance of Alphabet Inc.’s stock reflects the company’s current challenges and investor sentiment. With a closing price of $159.89, down $2.15 or -1.32%, the market is reacting to the ongoing developments. The stock’s movement…

Site Search

Company Search

Category: QualityStocksNewsBreaks